Virginia Vierra, MD | |
5063 Cottonwood St, Suite 160, Murray, UT 84107-6766 | |
(801) 507-1850 | |
(801) 507-1875 |
Full Name | Virginia Vierra |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 5063 Cottonwood St, Murray, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437181682 | NPI | - | NPPES |
1912097189 | Medicaid | UT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 51152961205 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Virginia Vierra, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 965-3600 | Virginia Vierra, MD 5063 Cottonwood St, Suite 160, Murray, UT 84107-6766 Ph: (801) 507-1850 |
News Archive
Researchers have used PET scans to train a machine-learning, artificial intelligence (AI) algorithm to detect early-stage Alzheimer's disease.
Baylor Health Care System is today announcing its intent to continue to improve the quality of patient care in North Texas through the implementation of the electronic health record (EHR) across the health care system. It is one of thousands of hospitals and eligible professionals across the country officially registering with the U.S. Department of Health and Human Services (HHS) to demonstrate its commitment to achieve "meaningful use" of EHRs.
Small proteins that affect communication between cells play an important role in regulating inflammation that occurs during inflammatory bowel disease, according to researchers at Georgia State University, Emory University, the University of Michigan and Amgen, a biotechnology company.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced the final results from the PROTECT II study, presented by William O'Neill, M.D., Dean of University of Miami and Principal Investigator of PROTECT II, at the American College of Cardiology's 60th Annual Scientific Session and i2 Summit 2011 in New Orleans.
Tetra Discovery Partners today announced that the company has initiated human Phase 1 safety trials of its lead compound BPN14770, which Tetra is developing as a potential treatment to both improve memory and slow the progression of Alzheimer's disease.
› Verified 9 days ago
Jennifer Lynn Makosky, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Dale L Chapman, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Dr. Paul E Wirkus, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Dr. John B Wall, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Jake C Jones, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Joseph A Roberts, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 164 E 5900 S, Ste A112, Murray, UT 84107 Phone: 801-262-2673 Fax: 801-269-9894 | |
Dr. Gary Warren Schlichter, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 164 E 5900 S, Ste. A112, Murray, UT 84107 Phone: 801-262-2673 Fax: 801-269-9894 |